Zum Inhalt

Advances in Therapy

Ausgabe 9/2025

Inhalt (38 Artikel)

Integration of Generative AI with Human Expertise in HEOR: A Hybrid Intelligence Framework

  • Open Access
  • Practical Approach

Tushar Srivastava, Hanan Irfan, Vladimir Babiy, Shilpi Swami

Ethnicity Risk and Exertional Rhabdomyolysis: A Narrative Review

  • Review

Angela Nguyen, Austin Thomassen, Ellie M. MacDonald, Victoria A. Rodriguez, John M. Brown, Sahar Shekoohi, Alan D. Kaye

Systematic Review and Meta-analysis of Long-Term Nusinersen Effectiveness in Adolescents and Adults with Spinal Muscular Atrophy

  • Open Access
  • Review

Tim Hagenacker, Angela D. Paradis, Katherine A. Lawson-Michod, Bora Youn

Trospium Chloride in the Treatment of Overactive Bladder Syndrome and Detrusor Overactivity

  • Open Access
  • Review

José C. Truzzi, Marair G. F. Sartori, Vitorio L. Kemp

Efficacy and Safety of TV-46000 and Second-Generation Long-Acting Injectable Antipsychotics for Schizophrenia: A Systematic Literature Review and Network Meta-Analysis of Randomized Controlled Trials

  • Open Access
  • Review

Kelli R. Franzenburg, Rolf Hansen, Mark Suett, Stephen F. Thompson, Martin Sergerie, David Garcia, Howard C. Margolese

Interferon in Liver Diseases: Recent Advances

  • Open Access
  • Review

Yuting Gao, Yuhang Yin, Pengpeng Xie, Deyu Zhang, Hongyu Li, Xingshun Qi

Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022–2023

  • Open Access
  • Review

Luis Puig, Philipp Sewerin, Christopher Schuster, Khai Jing Ng, Manny Papadimitropoulos, Sneha Gadagamma, Mercedes Nuñez, Anastasia Lampropoulou

Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval

  • Open Access
  • Review

Aliya A. Khan, Eric T. Rush, Craig Wakeford, Daniel Staub, Maria Luisa Brandi

Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation

  • Open Access
  • Original Research

Divyan Chopra, Zhiyi Lan, David M. Waterhouse, Jürgen Wolf, Enriqueta Felip, Hoora Moradian, Nadia Karim, Cynthia Obiozor, Björn Stollenwerk

Epidemiology and Steroid Dependency Reduction in Crohn’s Disease During the Biologics Era: A Nationwide Population-Based Study

  • Open Access
  • Original Research

Nai-Yu Chen, Chiao-Hsiung Chuang, Yu-Ching Chang, Yea-Huei Kao Yang, Hua Hsu, Chieh-Min Chen, Ching-Lan Cheng

Safety, Tolerability, and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients with Focal-Onset Seizures: Interim Analysis of a Phase 3 Open-Label Extension Trial

  • Open Access
  • Original Research

Ayataka Fujimoto, Bing Qin, Dimitrios Bourikas, Najla Dickson, Brian Moseley, Tomonobu Sano, Tadaharu Soma, Weiwei Sun, Jun Watanabe, Dong Zhou, Yushi Inoue

Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen in Patients with Schizophrenia

  • Open Access
  • Original Research

John Lauriello, Michael J. Doane, James A. McGrory, Alejandro G. Hughes, Lauren N. Strand

How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical® Hybrid Cannabis Extract

  • Open Access
  • Original Research

Yvonne Wagner, Ines Samel, Kristina Probst, Lukas Schollenberger, Christian Ruckes, Joachim Nadstawek

Challenges and Opportunities for Improving Management of Patients with nAMD and DME in China: Insights from a Global Survey on Anti-VEGF Therapy

  • Original Research

Xiaodong Sun, Yan Li, Zongming Song, Xiang Ma, Hong Yan, Shanshan Yu, Jingfa Zhang, Yanchun Wu, Zixu Huang, Haiyan Wang, Tao Bai, Jun Hu, Jing Tan, Xiaofeng Lin

Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality

  • Open Access
  • Original Research

Luciano Quaranta, Alessia A. Galbussera, Mauro Tettamanti, Alessio Novella, Luca Pasina, Ida Fortino, Olivia Leoni, Francesco Oddone, Sara Giammaria, Mikołaj Kużniak, Robert N. Weinreb, Alessandro Nobili

Survival Outcomes with Cilta-cel Versus Conventional Treatment Regimens for Patients with Lenalidomide-Refractory Multiple Myeloma Using Inverse Probability of Treatment Weighting

  • Open Access
  • Original Research

Rafael Fonseca, Joris Diels, Francesca Ghilotti, João Mendes, Sandra Van Hoorenbeeck, Seina Lee, Jordan M. Schecter, Nikoletta Lendvai, Nitin Patel, Ana Triguero, Winfried Alsdorf, Niels W. C. J. van de Donk, Margherita Ursi

Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy

  • Open Access
  • Original Research

Jadwiga A. Wedzicha, Stephen G. Noorduyn, Valentina Di Boscio, Olivier Le Rouzic, Anurita Majumdar, Rosirene Paczkowski, Stephen Weng, Guillaume Germain, François Laliberté, David Mannino

Burden of Atopic Dermatitis in Patients Initiating Systemic Therapies in the United States

  • Original Research

Matthew Zirwas, Nicole Princic, Megan K. Richards, Aamir Qureshi, Lorenzo Sabatelli, Peter Lio

Development of the Pediatric Weight Questionnaire (PWQ™) for Children and Adolescents with Obesity

  • Open Access
  • Original Research

Kristina S. Boye, Amy Clark, Chisom Kanu, Lisa M. Neff, Anne M. Skalicky

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan

  • Open Access
  • Original Research

Masaomi Nangaku, Kazuyo Sasaki, Jing Bi, Kiichiro Ueta, Kenichi Nishimura, Takafumi Hashimoto, Mihoko Hata

Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn’s Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey

  • Open Access
  • Original Research

David T. Rubin, Alison Potts Bleakman, Simon Travis, Marla Dubinsky, Stefan Schreiber, Remo Panaccione, Theresa Hunter Gibble, Cem Kayhan, Tommaso Panni, Eoin Flynn, Angelo D. Favia, Christian Atkinson, Sonal Saxena, Toshifumi Hibi

Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial

  • Original Research

Yan Zhao, Litao Zhang, Liming Wu, Bin Yang, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chao Ji, Chao Liang, Yanping Qiu, Bo Chen, Jianzhong Zhang

Pharmacokinetics and Safety of Ripretinib in Participants with Hepatic Impairment: A Phase 1 Study

  • Open Access
  • Original Research

Anna Papinska, Lakshmi Viswanathan, Qiang Lu, Farida Abane, Charles Psoinos, Rodrigo Ruiz-Soto

Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles

  • Open Access
  • Original Research

Kent A. Hanson, Jenny Austin, Nicola Clayton, Peter Anderson, Sergio Vano-Galvan, Simran Marwaha, Samantha K. Kurosky, Alexandre Lejeune, James Piercy, Ernest H. Law

Evaluating the Compositional Quality of Probiotics Containing Bacillus clausii in India

  • Open Access
  • Original Research

Dhanasekhar Kesavelu, Sridhar Ganpathy, Pramod Jog, Bhaswati Acharya, Vivek Saxena, Nivedita Telang, Nilesh Gaikwad

Real-World Prophylaxis Outcomes with rIX-FP and rFIXFc for Males with Hemophilia B: Pooled Analysis of Medical Chart Data from Germany and Italy

  • Open Access
  • Original Research

Johannes Oldenburg, Martin Olivieri, Songkai Yan, Ying Yang, Radovan Tomic, Xiang Zhang, Douglass Drelich, Natalie Jakobs, Mariasanta Napolitano

Evaluation of XSB-001 (Ranibizumab Biosimilar) Physicochemical and Biological Stability in Prepared Syringes for Intravitreal Injection

  • Open Access
  • Original Research

Robert Björnestedt, Sean Waters, Aušrinė Paišytė, Fabricio Furlan, Christian Wanner

Body Mass Index Progression, Development of Complications and Healthcare Costs Over 8 Years in UK Individuals Living With Overweight/Obesity

  • Open Access
  • Original Research

Luca Busetto, Silvia Capucci, João D. da Rocha Fernandes, Sara Holloway, Abd A. Tahrani, Andrew Thompson, Jonathan Pearson-Stuttard

Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan

  • Open Access
  • Original Research

Carlos de Castro, Richard J. Kelly, Morag Griffin, Christopher J. Patriquin, Brian Mulherin, Britta Höchsmann, Veena Selvaratnam, Raymond Siu Ming Wong, Peter Hillmen, Regina Horneff, Uchendu O. Uchendu, Yiwei Zhang, Elena Surova, Johan Szamosi, Regis Peffault de Latour

Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)

  • Open Access
  • Original Research

Hubert Marotte, Alain Cantagrel, Fabienne Coury, Thierry Schaeverbeke, Maryse Assing, Meriem Kessouri, Yves Brault, Bruno Fautrel

When Primary Ciliary Dyskinesia Is Diagnosed in Utero: Insights from Two Families

  • Open Access
  • Case Series

Israel Amirav, Moria Beer, Dorit Redlich Amirav, Moran Lavie

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration

  • Open Access
  • Brief Report

Victoria Navarro-Compán, John D. Reveille, Proton Rahman, José A. Maldonado-Cocco, Marina Magrey, Rebecca Bolce, Tommaso Panni, Andris Kronbergs, Martin Rudwaleit

Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

  • Open Access
  • Correction

Peter C. Taylor, Thomas Bieber, Rieke Alten, Torsten Witte, James Galloway, Walter Deberdt, Maher Issa, Ewa Haladyj, Inmaculada De La Torre, Susanne Grond, Andreas Wollenberg

Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study

  • Open Access
  • Correction

Mark G. Lebwohl, John Y. Koo, Janusz Jaworski, Jakub Trefler, Stefan Daniluk, Anna Dudek, Wojciech Baran, Witold Owczarek, Joanna Kolinek, Paweł Brzewski, Mariusz Sikora, Marek Krogulec, SungHyun Kim, YunJu Bae, DaBee Jeon, EunJin Choi, JungBin Cha, HyunJin Lee, SuJin Choi, David M. Pariser

Correction to: Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study

  • Open Access
  • Correction

Njira L. Lugogo, Praveen Akuthota, Kaharu Sumino, Sameer K. Mathur, Autumn F. Burnette, Andrew W. Lindsley, Jean-Pierre Llanos, Claudio Marchese, Christopher S. Ambrose, Benjamin Emmanuel

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Schlechter Geruchssinn als mögliches Anzeichen für erhöhtes KHK-Risiko

Ein nachlassender Geruchssinn könnte ein Hinweis auf ein erhöhtes Risiko für die koronare Herzkrankheit (KHK) sein. In einer Analyse von über 5.000 älteren Erwachsenen war die Assoziation in den ersten Jahren nach Testung am stärksten und nahm mit der Zeit ab.

Tiefere Diagnostik, mehr Therapietargets bei metastasiertem Brustkrebs

Eine umfangreichere molekulardiagnostische Aufarbeitung kann bei metastasiertem Brustkrebs mehr therapierelevante Angriffsstellen aufdecken als das Standardvorgehen, was sich in Behandlungsvorteile übersetzt. Dafür sprechen zumindest die ersten Ergebnisse der deutschen CATCH-Studie.     

Zystische Fibrose: Immer mehr Frauen können erfolgreich schwanger werden

Dank verbesserter Therapieoptionen können Frauen mit zystischer Fibrose (CF) heute häufiger Kinder bekommen. Eine retrospektive Analyse aus England zeigt, dass dabei nur selten Komplikationen auftreten.

Antisense-Medikament senkt Triglyzeride und Pankreatitis-Risiko

In zwei Phase-3-Studien zeigte eine Therapie mit dem Antisense-Oligonukleotid Olezarsen einen starken Triglyzerid-senkenden Effekt bei Betroffenen mit schwerer Hypertriglyzeridämie. Auch das Risiko für akute Pankreatitiden reduzierte sich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Eine ältere Frau riecht an einem Basilikumblatt/© Halfpoint / Stock.adobe.com (Symbolbild mit Fotomodell), Person setzt DNS-Probe in Maschine ein/© Vit Kovalcik / stock.adobe.com, Schwangere/© Yakobchuk Olena / Stock.adobe.com (Symbolbild mit Fotomodell)